This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PRGN-2012, a Novel Gorilla Adenovirus-Based IO, Provides the First Treatment That Leads to Complete & Durable Responses in Recurrent Respiratory Papillomatosis Patients"

78 views
June 7, 2024
Comments 0
Login to view comments. Click here to Login